Effect of Differential Enteral Protein on Growth and Neurodevelopment in Infants <1500 g: A Randomized Controlled

Shivani Dogra1, Anup Thakur, Pankaj Garg

  • 1Department of Neonatology, Institute of Child Health, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, India.

Insights

Higher protein intake in preterm infants improved head growth and weight gain by 40 weeks postmenstrual age (PMA). However, this enhanced nutrition did not show long-term benefits in growth or neurodevelopment at 12-18 months corrected age.

Area of Science:

  • Neonatal nutrition
  • Pediatric growth and development

Background:

  • Preterm infants (<32 weeks or 1500g) are at risk for growth faltering.
  • Optimizing nutrition, particularly protein intake, is crucial for their development.

Purpose of the Study:

  • To investigate if higher enteral protein intake improves head growth at 40 weeks postmenstrual age (PMA) in preterm infants.
  • To assess the impact of increased protein on weight gain and length in this vulnerable population.

Main Methods:

  • A randomized controlled trial involving 120 preterm infants.
  • Infants were assigned to receive either higher (Group A) or standard (Group B) enteral protein fortification of expressed breast milk.
  • Protein intake was monitored, and head circumference, length, and weight gain were measured up to 40 weeks PMA.

Main Results:

  • Group A demonstrated significantly higher weekly occipitofrontal circumference gain (0.66 cm/week vs. 0.60 cm/week) and weight growth velocity (11.95 g/kg/day vs. 10.78 g/kg/day) compared to Group B.
  • No significant differences in length gain were observed between the groups.
  • Growth indices and neurodevelopmental outcomes at 12-18 months corrected age were similar in both groups.

Conclusions:

  • Fortifying expressed human milk with higher protein content enhances head growth and weight gain in preterm infants by 40 weeks PMA.
  • These short-term nutritional benefits do not translate into improved long-term growth or neurodevelopmental outcomes at 12-18 months corrected age.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
622
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
414
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.5K
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
2.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
308